Oxcarbazepine-induced Stevens-Johnson syndrome: a case report

Kaohsiung J Med Sci. 2009 Feb;25(2):82-6. doi: 10.1016/S1607-551X(09)70045-2.

Abstract

Although carbamazepine (CBZ) is the most common cause of Stevens-Johnson syndrome (SJS), a new anticonvulsant, oxcarbazepine, which is structurally related to carbamazepine, has been shown to induce SJS, although extremely rarely. Recently, a strong association was found between human leukocyte antigen (HLA) B*1502 and CBZ-induced SJS/TEN in a Han Chinese population. Here, we report a case with SJS, which was induced by oxcarbazepine. HLA genotyping in the patient showed HLA-B*1518/B*4001. HLA-B*1518 is a HLA-B15 variant. The genetic significance of HLA-B*1518 in association with oxcarbazepine-induced SJS needs to be further studied.

Publication types

  • Case Reports

MeSH terms

  • Anticonvulsants / adverse effects*
  • Carbamazepine / adverse effects
  • Carbamazepine / analogs & derivatives*
  • Child
  • Genotype
  • HLA-B Antigens / genetics
  • HLA-B15 Antigen
  • Humans
  • Male
  • Oxcarbazepine
  • Stevens-Johnson Syndrome / chemically induced*
  • Stevens-Johnson Syndrome / etiology
  • Stevens-Johnson Syndrome / genetics
  • Stevens-Johnson Syndrome / pathology

Substances

  • Anticonvulsants
  • HLA-B Antigens
  • HLA-B15 Antigen
  • Carbamazepine
  • Oxcarbazepine